These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Gastroprotective properties of ebrotidine. A review. Slomiany BL; Piotrowski J; Slomiany A Arzneimittelforschung; 1997 Apr; 47(4A):459-67. PubMed ID: 9205744 [TBL] [Abstract][Full Text] [Related]
5. [Ebrotidine: an new alternative in peptic acid diseases]. Piqué JM Med Clin (Barc); 1997 Mar; 108(8):301-3. PubMed ID: 9121207 [No Abstract] [Full Text] [Related]
6. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data. Slomiany BL; Piotrowski J; Slomiany A Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747 [TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Helicobacter pylori to antimicrobial agents: effect of ebrotidine and ranitidine. Piotrowski J; Piotrowski E; Slomiany A; Slomiany BL J Physiol Pharmacol; 1995 Dec; 46(4):463-9. PubMed ID: 8770790 [TBL] [Abstract][Full Text] [Related]
11. [Ebrotidine in the eradicating treatment of H. pylori]. Fernández Bermejo M; García Grávalos R Gastroenterol Hepatol; 1998; 21(6):316. PubMed ID: 9711019 [No Abstract] [Full Text] [Related]
12. Studies on the protective effect of ebrotidine on experimental ulcers induced by non-steroidal anti-inflammatory drugs in healthy volunteers. Puscas I; Puscas C; Coltau M; Torres J; Márquez M; Herrero E; Fillat O; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):565-8. PubMed ID: 9205766 [TBL] [Abstract][Full Text] [Related]
13. Enhancement in the protective qualities of gastric mucus with combination therapy of ebrotidine and amoxicillin for H. pylori eradication. Slomiany BL; Piotrowski J; Slomiany A; Konturek JW; Domschke WW Gen Pharmacol; 1998 Aug; 31(2):227-31. PubMed ID: 9688464 [TBL] [Abstract][Full Text] [Related]
14. Effect of ebrotidine on gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide. Slomiany BL; Piotrowski J; Slomiany A J Physiol Pharmacol; 1999 Sep; 50(3):391-404. PubMed ID: 10574469 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of ebrotidine and ranitidine combined with amoxicillin and metronidazole in the eradication of Helicobacter pylori in patients with duodenal ulcer. Popiela T; Kulig J; Karcz D; Tabor J; Torres J; Márquez M; Fillat O; Herrero E; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):573-7. PubMed ID: 9205768 [TBL] [Abstract][Full Text] [Related]
16. Ebrotidine. A new generation H2-receptor antagonist and gastroprotective agent. Introduction. Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):427-30. PubMed ID: 9205737 [No Abstract] [Full Text] [Related]
17. Comparison of the efficacy and safety of ebrotidine in the treatment of duodenal ulcer. A multicentre, double-blind, placebo-controlled phase II study. Gabryelewicz A; Czajkowski A; Skrodzka D; Marlicz K; Luca de Tena F; Aldeguer M; Chantar C; Márquez M; Torres J; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):545-50. PubMed ID: 9205762 [TBL] [Abstract][Full Text] [Related]
19. Studies on the cytoprotective and antisecretory activity of ebrotidine. A review. Konturek PC; Brzozowski T; Konturek SI; Márquez M; Torres J; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):578-89. PubMed ID: 9205769 [TBL] [Abstract][Full Text] [Related]
20. Ebrotidine effect on the proteolytic and lipolytic activities of Helicobacter pylori. Slomiany BL; Piotrowski J; Mojtahed H; Slomiany A Gen Pharmacol; 1992 Mar; 23(2):203-6. PubMed ID: 1639232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]